These associations remained statistically significant even after being adjusted for tumor metastasis and patients’ age, suggesting that TCF12 could collaborate with MALAT1 to exacerbate CRC patients’ OS independently of patients’ age and tumor metastasis (Figure 1E). This evidence concerns the gene TCF12 and neoplasm.